CME Group Inc. (CME) Upgraded to Overweight at JP Morgan

Market Context

CME Group Inc. operates in the Financial Services sector. The stock currently trades at $304.16 with a market capitalization of $98.2B. The stock has gained 7.1% over the past 52 weeks.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. JP Morgan's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for CME Group Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 22, 2026	Piper Sandler	Overweight	N/A
Oct 22, 2026	JP Morgan	Overweight	N/A
Oct 14, 2026	Wells Fargo	Overweight	N/A
Oct 09, 2026	Morgan Stanley	Overweight	N/A
Oct 07, 2026	Barclays	Equal-Weight	N/A

Related Tools: Analyst Ratings Dashboard | View CME Stock Page